Patient safety and the COVID-19 pandemic: a qualitative study of perspectives of front-line clinicians.

Publication date: Aug 22, 2024

Studies on the impacts of COVID-19 on patient safety are emerging. However, few studies have elicited the perspectives of front-line clinicians. We interviewed clinicians from 16 US hospitals who worked in the emergency department, intensive care unit or inpatient unit during the COVID-19 pandemic. We asked about their experiences with both clinician well-being and patient care throughout the pandemic. We used a rigorous thematic analysis to code the interview transcripts. This study was part of a larger randomised control trial of an intervention to improve healthcare worker well-being during the COVID-19 pandemic; the findings described here draw from clinicians who spontaneously raised issues related to patient safety. 11 physicians and 16 nurses in our sample raised issues related to patient safety. We identified two primary themes: (1) compromised access to healthcare and (2) impaired care delivery. First, clinicians discussed how changes in access to healthcare early in the pandemic-including a shift to telehealth and deferred care-led to delays in accurate diagnosis and patients presenting later in their disease course. Second, clinicians discussed the effects of COVID-19 on care delivery related to staffing, equipment shortages and space constraints and how they deviated from the standard of care to manage these constraints. Clinicians noted how these issues led to patient safety events such as central line infections, patient falls and serious medication administration errors. Several well-intentioned interventions implemented in the early weeks of the pandemic created a unique context that affected patient safety throughout the pandemic. Future pandemic preparedness should consider planning that incorporates a patient safety lens to mitigate further harm from occurring during a public health crisis.

Open Access PDF

Concepts Keywords
Covid Adult
Future COVID-19
Nurses COVID-19
Pandemic Female
Physicians Health Personnel
Humans
Male
Pandemics
Patient Safety
Patient safety
Qualitative Research
SARS-CoV-2
Standards of care
United States

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH emergency
disease IDO intervention
disease IDO disease course
disease MESH infections
disease VO USA
disease MESH critically ill
disease MESH morbidity
drug DRUGBANK Coenzyme M
disease MESH burn out
disease VO protocol
disease IDO process
disease MESH cancers
disease MESH chronic diseases
drug DRUGBANK Etoperidone
disease VO volume
disease MESH respiratory failure
disease MESH death
drug DRUGBANK Propofol
drug DRUGBANK Ranitidine
disease IDO blood
drug DRUGBANK Oxygen
disease MESH heart failure
drug DRUGBANK Fentanyl
drug DRUGBANK Trestolone
disease MESH bloodstream infection
drug DRUGBANK Medical air
disease MESH moral injury
disease IDO infection
disease MESH pneumonia
disease MESH colon cancer
drug DRUGBANK Meticillin
drug DRUGBANK Vancomycin
disease VO frequency
disease VO organization
drug DRUGBANK L-Tyrosine
disease IDO infectious agent
disease VO publication
disease IDO quality
drug DRUGBANK Fenamole

Original Article

(Visited 2 times, 1 visits today)